---
title: "Magnesium Oxide - Postmenopausal Osteoporosis"
sidebar: mydoc_sidebar
permalink: db01377-mesh-d015663-1.html
toc: false 
---


Path ID: `DB01377_MESH_D015663_1`
{% include image.html url="images/db01377-mesh-d015663-1.png" file="db01377-mesh-d015663-1.png" alt="db01377-mesh-d015663-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D008277 | Magnesium oxide | Drug |
| MESH:D008274 | Magnesium | ChemicalSubstance |
| GO:0035898 | Parathyroid hormone secretion | BiologicalProcess |
| GO:0055074 | Calcium ion homeostasis | BiologicalProcess |
| MESH:D015663 | Postmenopausal osteoporosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Magnesium Oxide | INCREASES ABUNDANCE OF | Magnesium |
| Magnesium | REGULATES | Parathyroid Hormone Secretion |
| Parathyroid Hormone Secretion | POSITIVELY REGULATES | Calcium Ion Homeostasis |
| Calcium Ion Homeostasis | NEGATIVELY CORRELATED WITH | Postmenopausal Osteoporosis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01377](https://go.drugbank.com/drugs/DB01377)
